ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Successful Transplantation in ABO- and HLA-Incompatible Kidney-Transplant Patients.

    L. Rostaing, N. Congy, A. Allal, L. Esposito, F. Sallusto, N. Congy, X. Doumerc, B. Debiol, N. Kamar.

    Néphrologie et Transplantation d'Organes, CHU Rangueil, Toulouse, France; INSERM U 563, CHU Purpan, Toulouse, France; Faculté de Médecine de Rangueil, Université Toulouse III Paul Sabatier, Toulouse, France; INSERM U1043 CNRS UMR 5282, CHU Purpan, Toulouse, France.

    Introduction: ABO-incompatible (ABOi) and HLA-incompatible (HLAi) kidney transplantation using living donors is common place; however, few data have reported on the outcomes of ABOi/HLAi living-kidney…
  • 2016 American Transplant Congress

    Young, Caucasian, Better Educated and Less Socially Deprived Patients Are More Likely to Be Transplanted with a Living Donor Kidney in the UK.

    D. Wu,1 M. Robb,2 C. Watson,3 R. Ravanan,4 J. Forsythe,1 W. Metcalfe,1 C. Dudley,4 C. Bradley,5 H. Draper,6 A. Bradley,3 G. Oniscu.1

    1Royal Infirmary of Edinburgh, Edinburgh, United Kingdom; 2NHSBT, Bristol, United Kingdom; 3University of Cambridge, Cambridge, United Kingdom; 4Southmead Hospital, Bristol, United Kingdom; 5University of London, London, United Kingdom; 6University of Birmingham, Birmingham, United Kingdom.

    IntroductionLiving donor kidney transplantation (LDKT) has significant benefits over deceased donor kidney transplantation (DDKT) in terms of improved survival and timely access to transplant. There…
  • 2016 American Transplant Congress

    A Quantitative CD45 Immunohistochemical Assay Allows Precise and Reproducible Measurement of Inflammation in Renal Transplant Biopsies.

    V. Walavalkar,1 S. Bowman,1 L. Laszik,1 D. Ikle,2 S. Chandran,1 F. Vincenti,1 Z. Laszik.1

    1UCSF, San Francisco, CA; 2Rho, Chapel Hill, NC.

    Purpose: Total inflammation (TI) is an important variable for the pathologic work-up of transplant kidney biopsies (TxBx) in the Banff schema. However, current standard pathologic…
  • 2016 American Transplant Congress

    Transcriptome Profiles in Peripheral Blood of Kidney Graft Recipients.

    J.-W. Seo,1 H. Moon,1 Y.-G. Kim,1 K.-H. Jeong,1 S.-J. Ihm,2 J.-Y. Moon,1 S.-H. Lee.1

    1Division of Nephrology, Department of Internal Medicine, Kyung Hee University College of Medicine, Seoul, Republic of Korea; 2Department of Pathology, Kyung Hee University College of Medicine, Seoul, Republic of Korea.

    The discovery of sensitive noninvasive diagnosis and the development of immune management in the renal allograft recipients are required for long-term graft survival. Although the…
  • 2016 American Transplant Congress

    Use of Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma Does Not Increase Recurrence.

    A. Gupta, M. Ramsay, G. Saracino, T. Anthony, R. Goldstein, G. McKenna, N. Onaca, R. Ruiz, G. Klintmalm, P. Kim.

    Baylor University Medical Center, Dallas, TX.

    IntroductionAutotransfusion (AT) is rarely used in liver transplantation of hepatocellular carcinoma (HCC) patients due to the fear of disease transmission. Leukocyte depleting filters (LDF) can…
  • 2016 American Transplant Congress

    Live Donor Liver Transplantation with Older Donors Only Impacts on a Late HCV Recurrence.

    N. Goldaracena, G. Sapisochin, A. Barbas, M. Dib, D. Al-Adra, N. Selzner, M. Cattral, P. Greig, L. Lilly, I. McGilvray, G. Levy, A. Ghanekar, E. Renner, D. Grant, M. Selzner.

    Abdominal Organ Transplant, Toronto General Hospital, Toronto, ON, Canada.

    Introduction:Impact of donor age on HCV recurrence in live donor liver transplant (LDLT) recipients is controversial. We compared HCV progression in recipients receiving a graft…
  • 2016 American Transplant Congress

    Technique of “Loop V-Plasty” for Combined Reconstruction of the Middle Hepatic Vein and Multiple Inferior Right Hepatic Veins Using Single Polytetrafluoroethylene Graft in a Right Lobe Living Donor Liver Transplantation.

    T.-H. Chen, L. Noriega, A. Thorat, P.-C. Li, H.-R. Yang, S.-C. Hsu, L. Jeng, M.-L. Li.

    Organ Transplantation, China Medical University Hospital, Taichung, Taiwan.

    Outflow reconstruction is a crucial step in living donor liver transplantation(LDLT)for proper graft functioning as any inadequacy of the venous drainage can cause severe graft…
  • 2016 American Transplant Congress

    Development of Diabetic Glomerulosclerosis (DMGS) After Kidney Transplantation (KTX).

    F. Cosio, L. Cornell, M. Stegall.

    Transplant Center, Mayo Clinic, Rochester, MN.

    Introduction. Causes of death-censored KTX loss are multiple and often non-alloimmune mediated. Examination of KTX biopsies after 5 years revealed an increasing number of cases…
  • 2016 American Transplant Congress

    Cinacalcet Versus Pre-Transplant Parathyroidectomy in Renal Transplant Recipients: Single Centre Experience.

    G. Lucisano,1 R. Charif,1 K. Koutroutsos,1 D. Taube,1 F. Palazzo,2 M. Loucaidou.1

    1Renal and Transplant Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom; 2Centre for Endocrinology, Imperial College Healthcare NHS Trust, London, United Kingdom.

    Introduction:Hyperparathyroidism(HPT) often persists after renal transplantation(Tx). Cinacalcet(Cx) and parathyroidectomy(PTx) are possible treatments. It was reported that PTx may be followed by a reduction in Tx…
  • 2016 American Transplant Congress

    Impact of Preformed Anti-HLA Antibodies in the Outcomes of Kidney Transplantation.

    S. Santos,1 J. Malheiro,1 M. Costa,2 A. Campos,1 S. Pedroso,1 M. Almeida,1 L. Martins,1 L. Dias,1 C. Henriques,1 A. Cabrita.1

    1Nephrology, Hospital Santo António, CHP, Porto, Portugal; 2Nephrology, Centro Hospitalar Tondela-Viseu, Viseu, Portugal.

    Background:Anti-HLA antibodies are risk factors for acute and chronic rejection and allograft loss. Its detection represents a major advance and is widely used in organ…
  • « Previous Page
  • 1
  • …
  • 143
  • 144
  • 145
  • 146
  • 147
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences